NEW YORK (GenomeWeb) – Molecular diagnostics developer Luminex announced today that it has received clearance from the US Food and Drug Administration as well as CE-IVD marking for its in vitro diagnostic system, the Aries M1.

The M1 is a lower-throughout version of the company's Aries System, and is designed for use in smaller satellite labs. It extracts, amplifies, and detects nucleic acid targets from a variety of sample types, and can process up to six different samples and up to six PCR-based assays at a time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.